FIRST AIRED: March 4, 2019

Nice work! Enjoy the show!

×

You’re busy. We get it.

Stay on top of the news with our Editor’s Picks newsletter.

US Edition
Intl. Edition
Unsubscribe at any time. One click, it’s gone.

Thanks for signing up!

×

Transcript

00:00:00
the maker of prescription drugs oxycontin is exploring filing for bankruptcy as it faces some two thousand lawsuits accusing it of contributing to the deadly opioid crisis sources told Reuters exclusively on Monday that drug manufacturer Purdue pharma and it's well the owners the sector family well considering the move as the company faces potentially significant liabilities the problem that we see the lawsuits accuse Purdue of misleading doctors and patients about the risks associated with prolonged use of the drug Purdue has denied the allegations arguing that it's opioids carry FDA approved warning labels a bankruptcy filing would hold the lawsuits and allow Purdue to negotiate legal claims with plaintiffs under the supervision of a judge the news on Monday sent down shares of endo international and insist therapeutics to companies also named an opioid related lawsuits opioids including heroin and fentanyl were involved in over forty seven thousand overdose deaths in two thousand seventeen six times more than a decade ago according to the U. S. centers for disease control and prevention we are going to end the scorch of drug addiction last year US president Donald Trump signed a bipartisan bill to deal with the opioid crisis and promotes research into non addictive new drugs for pain management